Cargando…

Zika vaccine candidates progress through nonclinical development and enter clinical trials

Detalles Bibliográficos
Autor principal:	Barrett, Alan D T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707887/ https://www.ncbi.nlm.nih.gov/pubmed/29263861 http://dx.doi.org/10.1038/npjvaccines.2016.23

Ejemplares similares

Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
por: Barrett, Alan D. T.
Publicado: (2018)

Research and development of Zika virus vaccines
por: Dawes, Brian E, et al.
Publicado: (2016)

Modeling and Simulation at the Interface of Nonclinical and Early Clinical Drug Development
por: Visser, S A G, et al.
Publicado: (2013)

Nonclinical Development of BCG Replacement Vaccine Candidates
por: Velmurugan, Kamalakannan, et al.
Publicado: (2013)

Translation of Anticancer Efficacy From Nonclinical Models to the Clinic
por: Stroh, M, et al.
Publicado: (2014)

Developing Zika vaccines: the lessons for disease X
por: Barrett, Alan D. T.
Publicado: (2018)

Clinical Trials and Administration of Zika Virus Vaccine in Pregnant Women: Lessons (that Should Have Been) Learned from Excluding Immunization with the Ebola Vaccine during Pregnancy and Lactation
por: Schwartz, David A.
Publicado: (2018)

Strategies for the Nonclinical Safety Assessment of Vaccines
por: Wolf, Jayanthi J., et al.
Publicado: (2012)

Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines
por: Collins, Natalie D., et al.
Publicado: (2020)

The Challenge of Interpreting Alanine Aminotransferase Elevations in Clinical Trials of New Drug Candidates
por: Church, Rachel J., et al.
Publicado: (2020)

Current Progress in the Development of Zika Virus Vaccines
por: Zhou, Kehui, et al.
Publicado: (2021)

Quantitative Imaging Enters the Clinical Arena: A Personal Viewpoint
por: Nordstrom, Robert J.
Publicado: (2020)

Nonclinical safety assessment of repeated administration and biodistribution of ChAd3‐EBO‐Z Ebola candidate vaccine
por: Planty, Camille, et al.
Publicado: (2020)

Detecting Guillain-Barré syndrome caused by Zika virus using systems developed for polio surveillance
por: Kandel, Nirmal, et al.
Publicado: (2016)

Nucleocapsid as a next-generation COVID-19 vaccine candidate
por: Oronsky, Bryan, et al.
Publicado: (2022)

Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective
por: Hansen, Clairissa A, et al.
Publicado: (2023)

How Relevant Is Sexual Transmission of Zika Virus?
por: Althaus, Christian L., et al.
Publicado: (2016)

Zika Vaccine Development—Current Progress and Challenges for the Future
por: Maslow, Joel N.
Publicado: (2019)

Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
por: Staples, J. Erin, et al.
Publicado: (2020)

Lipid droplets in Zika neuroinfection: Potential targets for intervention?
por: Dias, Suelen Silva Gomes, et al.
Publicado: (2023)

Recruiting to preclinical Alzheimer's disease clinical trials through registries
por: Grill, Joshua D.
Publicado: (2017)

Regulatory developments in the conduct of clinical trials in India
por: Roy Chaudhury, R., et al.
Publicado: (2016)

Biosimilars entering the clinic without animal studies: A paradigm shift in the European Union
por: van Aerts, Leon AGJM, et al.
Publicado: (2014)

Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
por: Halstead, Scott B.
Publicado: (2017)

Nonclinical and clinical pharmacology evidence for cardiovascular safety of saxagliptin
por: Pollack, Pia S., et al.
Publicado: (2017)

Reporting bias in clinical trials: Progress toward transparency and next steps
por: Mitra-Majumdar, Mayookha, et al.
Publicado: (2022)

Environmental Enteric Dysfunction: A Case Definition for Intervention Trials
por: Denno, Donna M., et al.
Publicado: (2017)

Novel Vector Control Approaches: The Future for Prevention of Zika Virus Transmission?
por: von Seidlein, Lorenz, et al.
Publicado: (2017)

Cell Death And Zika Virus: An Integrated Network Of The Mechanisms Of Cell Injury
por: de Sousa, Jorge Rodrigues, et al.
Publicado: (2019)

Development of COVID-19 therapies: Nonclinical testing considerations
por: Baldrick, Paul
Publicado: (2022)

Travel Vaccines Enter the Digital Age: Creating a Virtual Immunization Record
por: Wilson, Kumanan, et al.
Publicado: (2016)

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease
por: Cardozo, Timothy, et al.
Publicado: (2020)

Monitor for COVID-19 vaccine resistance evolution during clinical trials
por: Kennedy, David A., et al.
Publicado: (2020)

The dynamics of poverty, educational attainment, and the children of the disadvantaged entering medical school
por: Baugh, Aaron D, et al.
Publicado: (2019)

Growing Problem of Multidrug-Resistant Enteric Pathogens in Africa
por: Okeke, Iruka N., et al.
Publicado: (2007)

Progress of Active Surveillance for Vaccine Safety in China
por: Liu, Zhike, et al.
Publicado: (2021)

Paracingulate Sulcus Morphology and Hallucinations in Clinical and Nonclinical Groups
por: Garrison, Jane R, et al.
Publicado: (2019)

Cryolipolysis: Clinical Best Practices and Other Nonclinical Considerations
por: Few, Julius, et al.
Publicado: (2020)

Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting
por: Quemeneur, Laurence, et al.
Publicado: (2018)

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective
por: Perazzolo, Simone, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f1sii2teu58dnq8ivu01nfquk6